GILD Gilead Sciences, Inc.
Healthcare$133.73-0.47%ClosedMarket Cap: $166.04B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$161.76
Target (Median)
$165.00
Target Range
$133.00 - $180.00
Upside from current price: 21.0%
Rating Distribution
6 Strong Buy18 Buy8 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Maxim Group | upgrade | Buy | Hold |
| 2026-05-08 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-05-08 | Truist Securities | maintain | Buy | Buy |
| 2026-04-13 | Citigroup | maintain | Buy | Buy |
| 2026-04-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-02-23 | Needham | maintain | Buy | Buy |
| 2026-02-11 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| 2026-02-11 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-02-11 | Truist Securities | maintain | Buy | Buy |
| 2026-02-11 | Cantor Fitzgerald | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.63 | $32.35B | 16 |
| Sun Dec 31 | $10.54 | $34.19B | 10 |
| Mon Dec 31 | $11.88 | $36.55B | 4 |
| Tue Dec 31 | $12.88 | $38.33B | 4 |